Professor, Medicine, Cooper Medical School of Rowan Univ
Hematology
Dr. Neil A. Lachant, MD
|
|
Give Review
Neil A. Lachant, MD practices Hematology. He went to medical school at SUNY Upstate Medical University. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. Neil A. Lachant is a published doctor as well. He has 45 publications published. The latest was: Physiologic concentrations of arginine vasopressin activate human platelets in vitro. He is registered with Medicare.
Publications
- Duplication of chromosome 1 dup(1)(q21q32) as the sole cytogenetic abnormality in a patient previously treated for AML.
- A sheep in wolf's clothing.
- The misuse of antibiotics for treatment of upper respiratory tract infections in children.
- Cultured circular smooth muscle from the rabbit colon.
- Ancrod infusion for antiCoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia.
- Heterogeneity of the aggregation response of human platelets to arginine vasopressin.
- Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
- Adult idiopathic Thrombocytopenic purpura. Clinical findings and response to therapy.
- HLA antigens and childhood Acute lymphocytic leukaemia.
- Impaired pentose phosphate shunt function in sickle cell Disease: a potential mechanism for increased Heinz body formation and membrane lipid peroxidation.
- Inhibition of the pentose phosphate shunt by 2,3-diphosphoglycerate in erythrocyte pyruvate kinase deficiency.
- CDP-choline does not inhibit erythrocyte glycolytic or pentose phosphate pathway enzyme activity.
- Antioxidant metabolism during blood storage and its relationship to posttransfusion red Cell survival.
- Inhibition of the pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning.
- Hemolytic Anemia in hereditary pyrimidine 5'-nucleotidase deficiency: nucleotide inhibition of G6PD and the pentose phosphate shunt.
- Hemolytic Anemia in hereditary pyrimidine 5''-nucleotidase deficiency. II. Effect of pyrimidine nucleotides and their derivatives on glycolytic and pentose phosphate s...
- Increased Heinz body formation and impaired erythrocyte pentose phosphate shunt function during pregnancy.
- Multicentric angiofollicular lymph node hyperplasia (Castleman's Disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndr...
- Impaired antioxidant defense in hemoglobin E-containing erythrocytes: a mechanism protective against malaria?
- Vaso-occlusive crisis-associated neutrophil dysfunction in patients with sickle-cell Disease.
- Antioxidants in sickle cell Disease: the in vitro effects of ascorbic acid.
- Dapsone-associated Heinz body hemolytic Anemia in a Cambodian woman with hemoglobin E trait.
- Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell Disease.
- Inhibitory effect of mannose on erythrocyte defense against oxidants.
- Hemoglobin E: an emerging hemoglobinopathy in the United States.
- Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.
- Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5''-nucleotidase deficiency.
- Decrease in subunit aggregation of phosphoribosylpyrophosphate synthetase: a mechanism for decreased nucleotide concentrations in pyruvate kinase-deficient human eryth...
- Effect of triethyltin on enzyme activity in human adult and cord red Cells.
- Red Cell metabolism in hereditary pyrimidine 5''-nucleotidase deficiency: effect of magnesium.
- Pyrimidine nucleotides do not affect the enzymes of glutathione biosynthesis.
- Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Morphologic and in situ hybridization studies.
- Relationship between the nicotinamide adenine dinucleotide redox potential and the 2,3-diphosphoglycerate content in the erythrocyte in sickle cell Disease.
- Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content.
- Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetas...
- Impaired erythrocyte phosphoribosylpyrophosphate formation in hemolytic Anemia due to pyruvate kinase deficiency.
- Impaired erythrocyte methemoglobin reduction in sickle cell Disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content.
- Dimethyl sulfoxide enhances hexose monophosphate shunt activity in cultured glomerular mesangial Cells, leukocytes and erythrocytes.
- Hereditary erythrocyte adenylate kinase deficiency: a defect of multiple phosphotransferases?
- Decreased pyrimidine nucleoside monophosphate kinase activity in sickle erythrocytes.
- Trabecular and integral bone density in adults with sickle cell Disease.
- Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic Cells.
- Physiologic concentrations of arginine vasopressin activate human platelets in vitro.
- Spontaneous remission in Acute myelogenous leukemia in the adult.
Schools
University Of Vermont College Of Medicine
SUNY Syracuse
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amalgamated Clothing & Textile Workers Union WC
- Amerigroup (Wellpoint)
- Local Value Network EPO
- Local Value Network HMO
- Local Value Network HMO+
- Local Value Network POS+
- Local Value Network PPO
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health America PPO
- Coventry Health Care of Delaware PPO
- GHI PPO
- Health Insurance Plan of Greater New York (HIP) PPO
- First Health (Coventry Health Care) PPO
- GEHA
- Advance EPO
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Principal Life
- QualCare HMO
- QualCare PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
SUNY Upstate Medical University -
University of Vermont College of Medicine
Hospital
-
Cooper University Health Care
Drug Facts
| NPI NUMBER | 1376625707 | |
| NPPES Provider LastName | LACHANT | |
| NPPES Provider FirstName | NEIL | |
| NPPES Provider ZIPCode | 080543419 | |
| NPPES Provider State | NJ | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 371.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1376625707 |
| Last Name Of The Provider | LACHANT |
| First Name Of The Provider | NEIL |
| View All |
Similar Doctors
|
Dr. Kumar Rajagopalan, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Monaliben A. Patel, MD |
|
Dr. Alexandre Hageboutros, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andres Ferber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rakesh Surapaneni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashwini Bhat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hady A. Ghanem, MD |
|
|
Dr. Danielle L. Behrens, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas F. Beach, MD |
|
Dr. Nati Lerman, MD
This Doctor is OpenDoctor Recommended.
|